Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma

计划入组 99 人 · 首次发布于 2018 年 7 月 19 日

Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma

计划入组 5 人 · 首次发布于 2019 年 9 月 30 日

PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome

计划入组 16 人 · 首次发布于 2016 年 4 月 19 日

Phosphodiesterase 3, 4 and 7 inhibitors (Spring Bank Pharmaceuticals)

Drotaverine

C₂₄H₃₁NO₄ · Rx

Roflumilast(Daliresp, Zoryve, Daxas)

C₁₇H₁₄Cl₂F₂N₂O₃

Xi'an No.4 Hospital

China

Guiyang No.4 People's Hospital

China

Huai'an No.4 People's Hospital

China

Union Therapeutics Advances Orismilast to Phase III for Atopic Dermatitis After Positive Phase IIb Results

Aurobindo's Acrotech Receives FDA Approval for ADQUEY, First Non-Steroidal PDE4 Inhibitor for Atopic Dermatitis

Transpire Bio Receives FDA Orphan Drug Designation for Inhaled Therapies Targeting IPF and Glioblastoma